Kenneth H Warrington

Title: Kenneth H Warrington: Innovator in Genetic Modification

Introduction

Kenneth H Warrington is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of genetic modification, particularly through his work on recombinant adeno-associated viral (rAAV) vectors. His innovative approaches have the potential to advance therapeutic applications in various medical fields.

Latest Patents

Kenneth H Warrington holds 1 patent for his invention titled "Raav expression systems for genetic modification of specific capsid proteins." This patent discloses improved rAAV vectors that feature mutations in one or more capsid proteins. The vectors presented have altered affinities for heparin or heparin sulfate. Additionally, the invention includes rAAV vector-based compositions, virus particles, host cells, and pharmaceutical formulations that are useful in expressing selected therapeutic proteins, polypeptides, peptides, antisense oligonucleotides, and ribozymes in selected mammals.

Career Highlights

Warrington is affiliated with the University of Florida Research Foundation Inc., where he continues to engage in groundbreaking research. His work has implications for the development of advanced gene therapies, which can significantly impact the treatment of various diseases.

Collaborations

Throughout his career, Kenneth H Warrington has collaborated with esteemed colleagues, including Nicholas Muzyczka and Shaun R Opie. These collaborations have fostered a productive research environment, leading to innovative solutions in genetic engineering.

Conclusion

Kenneth H Warrington's contributions to genetic modification through his patented inventions highlight his role as a key innovator in the field. His work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in science and medicine.